Mercury Bio
Business Services · New Mexico, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3900 Paseo Del Sol, Santa Fe, New Mexico...Phone Number
(800) 274-8533Website
www.mercurybio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Mercury Bio
Founded in 2020 and headquartered in Santa Fe, New Mexico, Mercury Bio has invented a drug delivery platform designed to unleash the potential of RNA and small-molecule drugs using reliable, cell-specific deliverytargeting only the cells that need therapy and working with the body to bypass immune reactions. Not only will the company's technology boost patient outcomes, it will help drug developers quicken products to market by reducing many of the obstacles, delays, and risks encountered by traditional drug delivery systems, spreading the viable reach of new medications in the process. By advancing drug efficacy, lowering costs, reducing side effects, and shortening time to market, the company aims to unlock the potential of new therapies and help make the worlds most advanced medicines more accessible to everyone.Explore more
Mercury Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mercury Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Mercury Bio recently announced quarterly report
Check if Mercury Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Mercury Bio launches new products
Website visits: Recent activity has been detected on your website
Mercury Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Mercury Bio had a recent Job posting/layoffs
Check out if Mercury Bio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Mercury Bio
Funding: Get notified immidiatlly once Mercury Bio has new funding data
Recommended Actions
Reach out to Masked Content who joined Mercury Bio as Masked Content
Find 2 more new buyers
Compare Similar Companies to Mercury Bio
Compare insights from companies similar to Mercury Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5M
11-50
Private
-
1984
PF
Pascal FortinEntrepreneur-in-Residence. President and Chief Scientific Officer, Stealth NewCo
Company Profile Activity
Activity Insights
Mercury Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mercury Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mercury Bio.
Mercury Bio financials insights
Gather financial insights about Mercury Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$2M
2025
Private Equity
$2.4M
Mercury Bio Tech Stack
A closer look at the technologies used by Mercury Bio
Most Recent Scoops
Funding
Funding
Person-Based
Person-Based
Event
Events
Executive Move
Board of Directors
Mercury Bio News & Media
Mercury Bio Launches MB-TIP™--Revolutionizing Immunotherapy with Intracellular Targeting
SANTA FE, N.M., Jan. 8, 2026 /PRNewswire/ -- Mercury Bio Inc. , an immunology-driven biotechnology company developing intracellular therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced MB-TIP™ (Mercury Bio - Targeting Intracellular Pathologies)...Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy & Business Development
SANTA FE, N.M., Dec. 9, 2025 /PRNewswire/ -- Mercury Bio, a company advancing intracellular delivery for central nervous system (CNS) therapeutics through its proprietary yEV™ platform, is pleased to announce the appointment of Cassandra "Casey" Perkins as Vice President of Corporate...Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors - BioSpace
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sectorMercury Bio Announces Biomolecular Research Project to Include Los Alamos National Laboratory, the National Center for Genome Resources, the University of New Mexico, and the University of Texas Medical Branch
SANTA FE, N.M., July 23, 2024 /PRNewswire/ -- Mercury Bio (www.mercurybio.com), a New Mexico-based biotech company focused on the development of a novel new drug-delivery platform, has significantly accelerated its research timeline via a strategic collaboration with four major scientific...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mercury Bio
Sign Up For FreeTo access detailed company insights
Founded in 2020 and headquartered in Santa Fe, New Mexico, Mercury Bio has invented a drug delivery platform designed to unleash the potential of RNA and small-molecule drugs using reliable, cell-specific deliverytargeting only the cells that need therapy and working with the body to bypass immune reactions. Not only will the company's technology b... Read More
